DNAVSEQS• 3 Months (Normalized)
DNA vs EQS (Ginkgo Bioworks Holdings Inc. vs Equus Total Return Inc.)
Showing Closing Date Range from Jul 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $11.47
+17.88%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
EQS Performance $0.8
-22.5%
Equus Total Return Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+40.38 pts
DNA outperforming by 40.38 percentage points
DNAEQS
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA EQS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | DNA Price | DNA Gain (%) | EQS Price | EQS Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $11.47 | +17.88% | $0.80 | -22.50% | +40.38% |
| Oct 06, 2026 | $12.41 | +27.54% | $0.81 | -20.88% | +48.42% |
| Oct 05, 2026 | $14.98 | +53.96% | $0.79 | -23.30% | +77.26% |
| Oct 02, 2026 | $12.35 | +26.93% | $0.88 | -14.56% | +41.49% |
| Oct 01, 2026 | $12.50 | +28.47% | $0.84 | -18.45% | +46.92% |
| Sep 30, 2026 | $12.83 | +31.86% | $0.93 | -9.71% | +41.57% |
| Sep 29, 2026 | $11.96 | +22.92% | $1.03 | +0.00% | +22.92% |
| Sep 28, 2026 | $10.46 | +7.50% | $- | - | |
| Sep 25, 2026 | $10.66 | +9.56% | $- | - | |
| Sep 24, 2026 | $10.25 | +5.34% | $- | - | |
| Sep 23, 2026 | $8.58 | -11.82% | $- | - | |
| Sep 22, 2026 | $9.37 | -3.70% | $- | - | |
| Sep 21, 2026 | $7.98 | -17.99% | $- | - | |
| Sep 18, 2026 | $7.88 | -19.01% | $- | - | |
| Sep 17, 2026 | $7.84 | -19.42% | $- | - |
Page 1 of 5